Matrix turnover in fibrogenesis

Hepato-Gastroenterology

Volumn 43, Issue 7, 1996, Pages 56-71

  Iredale, J P ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

2 macroglobulin; Collagenase; Liver fibrosis; Metalloproteinases; TIMPs

Indexed keywords

ALPHA 2 MACROGLOBULIN; COLLAGEN FIBRIL; COLLAGENASE; ENZYME PRECURSOR; GELATINASE; METALLOPROTEINASE; PLASMINOGEN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ENZYME ACTIVATION; FIBROGENESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REVIEW;

EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER CIRRHOSIS; METALLOENDOPEPTIDASES;

EID: 0029911680     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Friedman SL: The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N. Engl. J. Med. 1993; 328: 1828-1835.
2. Takase S, Leo MA, Nouchi T, Lieber CS: Desmin distinguishes cultured fat-storing cells from myofibroblasts, smooth muscle cells and fibroblasts in the rat. J. Hepatol. 1988; 6: 267-276.
3. Yokoi Y, Namihisa T, Kuroda H, et al: Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984; 4: 709-714.
4. Rockey DC, Boyles JK, Gabbiani G, Friedman SL: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicrosc. Cytol. Pathol. 1992; 24: 193-203.
5. Okanoue T, Burbige EJ, French SW: The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch. Pathol. Lab. Med. 1983; 107: 459-463.
6. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in Disse space. J. Hepatol. 1986; 3: 333-340.
7. Mak KM, Lieber CS: Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027-1033.
8. McGee JO, Patrick RS: The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver injury. Lab. Invest. 1972; 26: 429-440.
9. Minato Y, Hasumura Y, Takeuchi J: The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology 1983; 3: 559-566.
10. Rudolph R, McClure WJ, Woodward M: Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology 1979; 76: 704-709.
11. Takahara T, Kojima T, Miyabayashi C, et al: Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab. Invest. 1988; 59: 509-521.
12. Kent G, Gay S, Inouye T, Bahu R, Minick OT, Popper H: Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc. Natl. Acad. Sci. USA 1976; 73: 3719-3722.
13. Maher JJ, McGuire RF: Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J. Clin. Invest. 1990; 86: 1641-1648.
14. 4-induced injury. Federation Proceedings 39 (1980) abstr; 877 :.
15. Okazaki I, Maruyama K: Collagenase activity in experimental hepatic fibrosis. Nature 1974; 252: 49-50.
16. Carter EA, McCarron MJ, Alpert E, Isselbacher KJ: Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology 1982; 82: 526-534.
17. Perez-Tamayo R, Montfort I, Gonzalez E: Collagenolytic activity in experimental cirrhosis of the liver. Exp. Mol. Pathol. 1987; 47: 300-308.
18. Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS: Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 1982; 30: 1379-1384.
19. Maruyama K, Okazaki I, Kobayashi T, Suzuki H, Kashiwazaki K, Tsuchiya M: Collagenase production by rabbit liver cells in monolayer culture. J. Lab. Clin. Med. 1983; 102: 543-550.
20. Truden JL, Boros DL: Detection of alpha-2-macroglobulin, alpha-1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice. Am. J. Pathol. 1988; 130: 281-288.
21. Barsky SH, Gopal Krishna R: High metallo-proteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance. J. Natl. Cancer Inst. 1988; 80: 102-108.
22. Montfort I, Perez-Tamayo R, Alvizouri AM, Tello E: Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver. Virchows Archiv. B. Cell Pathol. 1990; 59: 281-289.
23. Maruyama K, Feinman L, Okazaki I, Lieber CS: Direct measurement of neutral collagenase activity in homogenates from baboon and human liver. Biochim. Biophys. Acta 1981; 658: 121-131.
24. Takahashi S, Dunn MA, Seifter S: Liver collagenase in murine schistosomiasis. Gastroenterology: 1980; 78: 1425-1431.
25. Takahashi S, Simpser E: Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis. Hepatology 1981; 1: 211-220.
26. Takahashi S, Koda K: Radioimmunoassay of soluble and insoluble collagenases in fibrotic liver. Biochem. J. 1984; 220: 157-164.
27. Montfort I, Perez-Tamayo R: Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am. J. Pathol. 1978; 92: 411-420.
28. Hunt J: Long-term follow-up of patients with hepatitis B treated with interferon. Interferons and Cytokines 1992; 20: 6-9.
29. Bissell DM, Arenson DM, Maher JJ, Roll FJ: Support of cultured hepatocytes by a laminin-rich gel. J. Clin. Invest. 1987; 79: 801-812.
30. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. Biol. Chem. 1989; 264: 10756-10762.
31. Murphy G, Docherty AJP, Hembry RM, Reynolds JJ: Metalloproteinases and tissue damage. Br. J. Rheumatol. (Suppl 1991; 30, 1): 25-31.
32. Birkedal-Hansen H: From tadpole collagenase to a family of matrix metalloproteinases. J. Oral Pathol. 1988; 17: 445-451.
33. Fillmore HL, Mainardi CL, Hasty KA: Differentiation of PC12 cells with nerve growth factor is associated with induction of transin synthesis and release. J. Neurosci. Res. 1992; 31: 662-669.
34. Murphy G, Hembry RM, Hughes CE, Fosang AJ, Hardingham TE: Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 1990; 18: 812-815.
35. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodelling. Trend Genet. 1990; 6: 121-125.
36. Southgate KM, Davies M, Booth RFG, Newby AC: Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem. J. 1992; 288: 93-99.
37. Waxman J, Wasan H: The architecture of cancer. The tissue metalloproteinases and their inhibitors. Br. Med. J. 1992; 305: 1306-1308.
38. Opdenakker G, Masure S, Grillet B, Van Damme J: Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 1991; 10: 319-324.
39. Woessner JF, Gunja-Smith Z: Role of metalloproteinases in human osteoarthritis. J. Rheumatol. 18 (1991; S27): 99-101.
40. Murphy G, Hembry RM: Proteinases in rheumatoid arthritis. J. Rheumatol. 1992; 19: 61-64.
41. Parish CR, Jakobsen KB, Coombe DR: A basement-membrane permeability assay which correlates with the metastatic potential of tumor cells. Int. J. Cancer 1992; 52: 378-383.
42. Bonfil RD, Medina PA, Gomez DE, Farias E, Lazarowski A, Gritti MFL, Meiss RP, Bustuoabad OD: Expression of gelatinase/type-IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion. Clin. Exp. Metastasis 1992; 10: 211-220.
43. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-463.
44. Werb Z: In: Jayson JM, Weiss JB Eds.: Collagen in Health and Disease, pp. 121-134. New York: Churchill Livingstone 1982.
45. Murphy G, Docherty AJP: The matrix metalloproteinases and their inhibitors Am J Respir Cell Mol Biol 1992; 7: 120-125.
46. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-65.
47. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y: Progesterone regulates the activity of collagenase and related gelatinase-A and gelatinase-B in human endometrial explants. Proc. Natl. Acad. Sci. USA 1992;89:11789-11793.
48. Conca W, Kaplan PB, Krane SM: Increases in levels of procollagenase mRNA in cultured fibroblasts induced by human recombinant IL-1 beta or serum follow c-jun expression and are dependent on new protein synthesis. J. Clin. Invest. 1989; 83: 1753-1757.
49. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumor necrosis factor-α Nature 1989; 337: 661-663.
50. Chamberlain SH, Hemmer RM, Brinckerhoff CE: Novel phorbol ester response region in the collagenase promoter binds fos and jun. J. Cell. Biochem. 1993; 52: 337-351.
51. Edwards DR, Rocheleau H, Sharma RR, Wills AJ, Cowie A, Hassell JA, Heath JK: Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1992; 1171: 41-55.
52. Schonthal A, Herrlich P, Rahmsdorf HJ, Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988; 54: 325-334.
53. Buttice G, Quinones S, Kurkinen M: The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res. 1991; 19: 3723-3731.
54. Shapiro SD, Doyle GAR, Ley TJ, Parks WC, Welgus HF: Molecular mechanisms regulating the production of collagenase and TIMP in U937 cells - evidence for involvement of delayed transcriptional activation and enhanced messenger RNA stability. Biochemistry 1993; 32: 4286-4292.
55. Auble DT, Brinckerhoff CE: The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase I in fibroblasts. Biochemistry 1991; 30: 4629-4635.
56. Wright JK, Clark IM, Cawston TE, Hazleman BL: The secretion of the tissue inhibitor of metalloproteinases (TIMP) by human synovial fibroblasts is modulated by all-trans-retinoic acid. Biochim. Biophys. Acta 1991; 1133: 25-30.
57. Clark SD, Kobayashi DK, Welgus HG: Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest. 1987; 80: 1280-1288.
58. Lafyatis R, Kim S-J, Angel P, Roberts AB, Sporn MB, Kann M, Wilder RL: Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol. Endocrinol. 1990; 4: 973-980.
59. Pan LY, Chamberlain SH, Auble DT, Brinckerhof CEF. Differential regulation of collagenase gene expression by retinoic acid receptor-α, receptor-β and receptor-γ Nucleic Acids Res 1992; 20: 3105-3111.
60. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD: Negative regulation of gene expression by TGF-β. Mol. Reprod. Dev. 1992; 32: 111-120.
61. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. New York Acad. Sci. 1992; 667: 1-12.
62. Corcoranm ML WG Stetlerstevenson, Brown PD, Wahl LM: Interleukin-4 inhibition of prostaglandin-E2 synthesis blocks interstitial collagenase and 92-kDa type-IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 1992; 267: 515-519.
63. Van Wart HE, Birkeda Hl-Hansen: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 1990; 87: 5578-5582.
64. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ: Stromelysin is an activator of procollagenase. Biochem. J. 1987; 248: 265-268.
65. Nagase H, Enghild JJ, Suzuki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 1990; 29: 5783-5789.
66. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase-9 (92-kDa gelatinase/type-IV collagenase) from HT-1080 human fibrosarcoma cells - purification and activation of the precursor and enzymic properties. J. Biol. Chem. 1992; 267: 21712-21719.
67. Gruber BL, Marchee MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, Ramamurthy NS: Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 1989; 84: 1657-1662.
68. Ward RV, Atkinson SJ, Slocombe PM, Docherty AJP, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta 1991; 1079: 242-246.
69. Murphy G: The regulation of connective tissue metalloproteinases by natural inhibitors. Progress Inflammation Research and 1991; Therapy: 3569-3576.
70. Enghild JJ, Salvesen G, Brew K, Nagas HE: Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (matrix metalloproteinase 3) with human α-2-macroglobulin and chicken ovostatin J Biol Chem 1989; 264: 8779-8785.
71. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA) -structure, control of expression and biological functions. Pharmacol. Ther. 1993; 59: 329-341.
72. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 66-69.
73. Boone TC, Johnson MJ, D YADe Clerck, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl. Acad. Sci. USA 1990; 87: 2800-2804.
74. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP: A new inhibitor of metalloproteinases from chicken -ChIMP-3 - a 3rd member of the TIMP family. J. Biol. Chem. 1992; 267: 17321-17326.
75. Cawston TE, Curry VA, Clark IM, Hazleman BL: Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. Biochem. J. 1990; 269: 183-187.
76. Curry VA, Clark IM, Bigg H, Cawston TE: Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72000-Mr progelatinase. Biochem. J. 1992; 285: 143-147.
77. Yang TT, Hawkes SP: Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 1992; 89: 10676-10680.
78. Murphy G, Koklitis P, Carne AF: Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. Biochem. J. 1989; 261: 1031-1034.
79. Arthur MJP: Matrix degradation in the liver. In: Eds. Surrenti, C., A. Casini, S. Milani, M. Pinzani: Fat-Storing Cells and Liver Fibrosis, pp. 110-127. Dordrecht: Kluwer Academic Publishers 1994.
80. Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, Hoidal JR, Welgus HG: Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells - cellular differentiation influences expression. J. Clin. Invest. 1993; 91: 1792-1799.
81. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6: 1899-1904.
82. Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J. Biol. Chem. 1991; 266: 14064-14071.
83. Overall CM, Wrana JL, Sudek J: Independent regulation of collagenase, 72kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem. 1989; 264: 1860-1869.
84. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. J. Clin. Invest. 1992; 89:: 19-27.
85. Friedman SL, Yamasaki G: Characterisation of TGF-β receptors in cultured rat lipocytes; enhanced receptor expression accompanies cellular activation. Hepatology 1991; 14: 113A.
86. Richards CD, Shoyab M, Brown TJ, Gauldie J: Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 1993; 150: 5596-5603.
87. Murphy G, Reynolds JJ, Werb Z: Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. J. Biol. Chem. 1985; 260: 3079-3083.
88. De Clerck YA,-TS Yean, Lu HS, Ting J, Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 1991; 266: 3893-3899.
89. Murphy G, Cawston TE, Reynolds JJ: An inhibitor of collagenase from human amniotic fluid. Biochem. J. 1981; 195: 167-170.
90. Cawston TE, Murphy G, Mercer E, Galloway WA, Hazleman BL, Reynolds JJ: The interaction of purified rabbit bone collagenase with pruified rabbit bone metalloproteinase inhibitor. Biochem. J. 1983; 211: 313-318.
91. Howard EW, Banda MJ: Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. J. Biol. Chem. 1991; 266: 17972-17977.
92. Howard EW, Bullen EC, Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 1991; 266: 13064-13069.
93. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetle Stevenson WB: Domain structure of human 72-kDa gelatinase type-IV collagenase characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem. 1992; 267: 15398-15405.
94. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL: Interaction of 92-kDa type-IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 1992; 267: 4583-4591.
95. Shah M, Foreman DM, Ferguson MWJ: Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992; 339: 213-214.
96. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.
97. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga F, Kehrl JH, Fauci AS: Transforming growth actor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 1986; 83: 4167-4171.
98. Casini A, Pinzani M, Milani S, Galli G, Salzano R, Rotella CM, Surrenti C: Regulation of extracellular matrix synthesis by transforming growth factor-beta 1 (TGF-β1) in human fat-storing cells (hFSC). J. Hepatol. 18(Suppl 1) (1993) abstr; S6 :.
99. Matsuoka M, Tsukamoto H: Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11: 599-605.
100. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE: Transforming growth factor-b enhances integrin expression and type-IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 1993; 90: 4577-4581.
101. Weiner FR, Degl Si Esposti, Zern MA: A role for transforming growth factor-beta in hepatic fibrogenesis. In: Surrenti, C., A. Casini, S. Milani, M. Eds.; Pinzani:: Fat-Storing Cells and Liver Fibrosis, pp. 199-208. Dordrecht: Kluwer Academic Publishers 1994.
102. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor-β 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 1990; 85: 1833-1843.
103. Nakatsukasa H, Evarts RP, Hsia CC, Thorgeirsson SS: Transforming growth factor-β 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab. Invest. 1990; 63: 171-180.
104. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-374.
105. Strobel D, Wittekind CH, Ruoslahti E, Hahn EG: In vivo application of a neutralising TGF-β antibody in experimental liver fibrosis. J. Hepatol. 18 (Suppl 1993; 1): S63. .
106. 4 induced liver fibrosis and activated human hepatic lipocytes. In: Wisse, E., K. Wake, D.L. Knook (Eds.): Cells of the Hepatic Sinusoid, Vol 5. Leiden: The Kupffer Cell Foundation 1995 (ress; in:.
107. Arthur MJP, Iredale JP, Murphy G: Tissue inhibitor of metalloproteinase-1 is expressed by culture activated human hepatic lipocytes and in fibrotic human liver. Q. J. Med. 1993; 86: 546-547.
108. Benyon RC, Iredale JP, Ferris WF, Arthur MJP: Increased expression of mRNA for gelatinase A and TIMP-2 in human fibrotic liver disease. Hepatology 1993; 18: 198A.
109. Vyas SK, Gentry J, Arthur MJP: Transin release by rat lipocytes in primary culture. Gut 1994; 35: A721-A722.
110. Arthur MJP, Friedman SL, Roll FJ, Bissell DM: Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (IV type: collagen, J. Clin. Invest. 1989; 84: 1076-1085.
111. Arthur MJP, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL: Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes: Analysis of gene expression, protein synthesis and proteinase activity. Biochem. J. 1992; 287: 701-707.
112. Arthur MJP, Jackson CL, Friedman SL: Release of type IV collagenase by human lipocytes. In: Eds.; Wisse, E., D.L. Knook, R.S. McCuskey: Cells of the Hepatic Sinusoid, Vol 3, pp. 161-163. Leiden: The Kupffer Cell Foundation 1991.
113. Winwood PJ, Kowalsk Pi-Saunders, Green I, Murphy G, Hembry RM, Arthur MJP: Kupffer cells release a 95kD gelatinase. In: Clement B, Eds.; Guillouzo A: Cellular and Molecular Aspects of Cirrhosis, pp. 307-310. France: John Libbey Eurotext Ltd/Colloque INSERM 1992.
114. Winwood PJ, Schuppan D, Arthur MJP: Partial purification and biochemical characterisation of Kupffer cell-derived 95kD gelatinase. Hepatology 1992; 16: 606. .
115. Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJP, Arthur MJP: Kupffer cell-derived 95kDa type IV collagenase/gelatinase B: Characterization and expression in cultured cells. Hepatology (in press 1995).
116. Laskin DL: Nonparenchymal cells and hepatotoxicity. Semin. Liver Dis. 1990; 10: 293-304.
117. Zerbe O, Gressner AM: Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp. Mol. Pathol. 1988; 49: 87-101.
118. 4-treated rat livers induce skin fibroblast and liver fat-storing cell proliferation in culture. Matrix 1989; 9: 150-158.
119. Friedman SL, Arthur MJP: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet derived growth factor receptors. J. Clin. Invest. 1989; 84: 1780-1785.
120. Iredale JP, Winwood PJ, Choudhury AK, Hembry RM, Murphy G, Arthur MJP: Lipocyte proliferation in the C. parvum model of macrophage-induced liver injury is associated with expression of 72kDa type IV collagenase/gelatinase. In: Knook, D.L., Wisse E. Eds.; Cells of the Hepatic Sinusoid, Vol 4, pp. 105-108. Leiden: The Kupffer Cell Foundation 1993.
121. Alcorn JM, Sheffield MF, Sweatman J, Argyres D: The expression of the matrix metalloproteinase transin but not collagenase is increased in regenerating rat liver. Hepatology 1992; 16: 140A.
122. Herbst H, Heinrichs O, Schuppan D, Milani S, Stein H: Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Archiv. B. Cell Pathol. 1991; 60: 295-300.
123. Leyland H, Benyon RC, Vyas SK, Arthur MJP: The plasminogen activating system in hepatic lipocytes and its modulation by retinoic acid. Hepatology 1994; 20: 293A.
124. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJP: Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-(TIMP-1): Implications for regulation of matrix degradation in liver. J. Clin. Invest. 1992; 90: 282-287..
125. Kordula T, Guttgemann I, Rosejohn S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L: Synthesis of tissue inhibitor of metalloproteinase-1 in human hepatoma HepG2 cells: up-regulation by interleukin-6 and transforming growth factor-β1. FEBS Lett. 1992; 313: 143-147...
126. Andus T, Gross V, Tran-Thi T-A, Schreiber G, Nagashima M, Heinrich PC: The biosynthesis of acute-phase proteins in primary cultures of rat hepatocytes. Eur J Biochem 1983; 133: 561-571.
127. Friedman SL: 'Cuts both ways' - collagenases, lipocyte activation and polyunsaturated lecithin. Hepatology 1992; 15: 549-551.
128. Milani S, Pinzani M, Casini A, Schuppan D, Herbst H, Grappone C, Pellegrini G, Gentilini A, Surrenti C: Interstitial collagenase gene is differentially expressed in human liver and cultured fat-storing cells. Hepatology 1992; 16: 186A.
129. Murawaki Y, Yamamoto H, Kawasaki H, Shima H: Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepato-cellular carcinoma. Clin. Chim. Acta 1993; 218: 47-58.
130. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y, Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J. Gastroenterol. Hepatol. 1993; 8: 437-441.
131. Murawaki Y, Kawasaki H, Burkhardt H: Serum collagenase activity in chronic liver diseases. Pathol. Res. Pract. 1994; 190: 929-933.
132. Fukuda Y, Imoto M, Koyama Y, Miyazawa Y, Nakano I, Hattori M, Urano F, Kodama S, Iwata K, Hayakawa T: Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol. Jpn. 1991; 26: 37-41.
133. Fujiwara K, Sakai T, Oda T, Igarashi S: The presence of collagenase in Kupffer cells of the rat liver. Biochem. Biophys. Res. Commun. 1973; 54: 531-537.
134. Bhatnagar R, Schade U, Rietschel ET, Decker K: Involvement of prostaglandin E and adenosine 3′5′-monophosphate in lipopolysaccharide-stimulated collagenase release by rat Kupffer cells. Eur. J. Biochem. 1982; 124: 125-130.
135. Emonard H, Guillouzo A, Lapiere ChM, Grimaud JA: Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro. Cell. Mol. Biol. 1990; 36: 461-467.
136. Nagase H, Barrett AJ, Woessner JF Jr: Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1992; 1: 421-424.